Taiko Pharmaceutical Co.,Ltd. (4574.T)

JPY 276.0

(0.36%)

Net Income Summary of Taiko Pharmaceutical Co.,Ltd.

  • Taiko Pharmaceutical Co.,Ltd.'s latest annual net income in 2022 was -4.89 Billion JPY , up 48.98% from previous year.
  • Taiko Pharmaceutical Co.,Ltd.'s latest quarterly net income in 2023 Q2 was -271 Million JPY , down -11.52% from previous quarter.
  • Taiko Pharmaceutical Co.,Ltd. reported an annual net income of -9.59 Billion JPY in 2021, down -349.07% from previous year.
  • Taiko Pharmaceutical Co.,Ltd. reported an annual net income of 3.85 Billion JPY in 2020, up 56.98% from previous year.
  • Taiko Pharmaceutical Co.,Ltd. reported a quarterly net income of -271 Million JPY for 2023 Q2, down -11.52% from previous quarter.
  • Taiko Pharmaceutical Co.,Ltd. reported a quarterly net income of -243 Million JPY for 2023 Q1, up 85.81% from previous quarter.

Annual Net Income Chart of Taiko Pharmaceutical Co.,Ltd. (2022 - 2007)

Historical Annual Net Income of Taiko Pharmaceutical Co.,Ltd. (2022 - 2007)

Year Net Income Net Income Growth
2022 -4.89 Billion JPY 48.98%
2021 -9.59 Billion JPY -349.07%
2020 3.85 Billion JPY 56.98%
2019 2.45 Billion JPY 73.33%
2018 1.41 Billion JPY 29.27%
2017 1.09 Billion JPY 4.34%
2016 1.04 Billion JPY 24.91%
2015 840.11 Million JPY -52.55%
2014 1.77 Billion JPY 1.33%
2013 1.74 Billion JPY 68.4%
2012 1.03 Billion JPY 115.16%
2011 482.2 Million JPY 121.64%
2010 -2.22 Billion JPY -235.44%
2009 1.64 Billion JPY 249.45%
2008 470.77 Million JPY 30.61%
2007 360.43 Million JPY 0.0%

Peer Net Income Comparison of Taiko Pharmaceutical Co.,Ltd.

Name Net Income Net Income Difference
Pharma Foods International Co., Ltd. 3.2 Billion JPY 252.699%
Takeda Pharmaceutical Company Limited 144.06 Billion JPY 103.397%
Sumitomo Pharma Co., Ltd. -314.96 Billion JPY 98.446%
Shionogi & Co., Ltd. 162.03 Billion JPY 103.02%
Wakamoto Pharmaceutical Co.,Ltd. 108.95 Million JPY 4591.598%
Nippon Shinyaku Co., Ltd. 25.85 Billion JPY 118.932%
Kaken Pharmaceutical Co., Ltd. 8.02 Billion JPY 160.984%
Eisai Co., Ltd. 42.4 Billion JPY 111.541%
Morishita Jintan Co., Ltd. 697 Million JPY 802.152%
Hisamitsu Pharmaceutical Co., Inc. 13.96 Billion JPY 135.035%
Mochida Pharmaceutical Co., Ltd. 4.54 Billion JPY 207.631%
Fuso Pharmaceutical Industries,Ltd. 1.37 Billion JPY 455.41%
Nippon Chemiphar Co., Ltd. -180 Million JPY -2618.889%
Tsumura & Co. 16.7 Billion JPY 129.293%
Kissei Pharmaceutical Co., Ltd. 11.16 Billion JPY 143.853%
Torii Pharmaceutical Co., Ltd. 4.11 Billion JPY 218.815%
Towa Pharmaceutical Co., Ltd. 16.17 Billion JPY 130.26%
Fuji Pharma Co., Ltd. 3.43 Billion JPY 242.475%
Zeria Pharmaceutical Co., Ltd. 7.73 Billion JPY 163.301%
KYORIN Holdings, Inc. 5.32 Billion JPY 191.958%
Daito Pharmaceutical Co.,Ltd. 3.29 Billion JPY 248.528%
SymBio Pharmaceuticals Limited -1.96 Billion JPY -149.336%
MedRx Co., Ltd -932 Million JPY -425.107%
Mizuho Medy Co.,Ltd. 3.77 Billion JPY 229.669%
Solasia Pharma K.K. -1.11 Billion JPY -340.108%
Modalis Therapeutics Corporation -2.39 Billion JPY -104.614%
ASKA Pharmaceutical Holdings Co.,Ltd. 7.54 Billion JPY 164.864%
Sawai Group Holdings Co., Ltd. 13.69 Billion JPY 135.736%
Cyfuse Biomedical K.K. -589.21 Million JPY -730.602%
Toho Holdings Co., Ltd. 20.65 Billion JPY 123.692%
Koa Shoji Holdings Co.,Ltd. 2.94 Billion JPY 266.105%